US2017298020A1PendingUtilityA1
Methods and compounds for treating proliferative disorders and viral infections
Assignee: UNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLINPriority: Apr 17, 2012Filed: Jun 23, 2017Published: Oct 19, 2017
Est. expiryApr 17, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A61P 31/12A61P 35/00A61K 31/64C07C 2601/14C07D 213/89C07D 277/34C07D 307/52C07D 213/34C07D 261/08C07D 213/85C07C 311/58C07D 213/71C07D 305/08C07C 311/59C07D 263/48C07D 307/42A61K 31/215C07D 231/12A61K 31/136C07D 205/04C07D 213/53C07D 295/192A61K 31/18A61K 31/216
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention generally relates to methods and compounds for treating proliferative disorders, viral infections, or both. In some embodiments, the invention provides an anticancer or antiviral compound including a substituted nitro phenoxy phenyl, a sulfonylurea, and an alkyl group. In some embodiments, the invention provides a method of treating a proliferative disorder or a viral infection including administering an anticancer or antiviral compound that binds to a thromboxane receptor, has preferential binding for either TPalpha (TPα) or TPbeta (TPβ) receptor subtype.
Claims
exact text as granted — not AI-modified1 - 46 . (canceled)
47 . A method of treating a viral infection or inflammatory condition, the method comprising administering a compound of formula (CXII):
wherein:
R 14 is selected from the group consisting of: an alkyl group, a branched alkyl group, and a cycloalkyl group;
R 15 is selected from the group consisting of
with R 3 selected from the list consisting of OH, and I; and
R 16 is selected from the group consisting of —NO 2 and —CN, or a pharmaceutically acceptable salt thereof.
48 . The method of claim 47 , wherein the compound is of formula (CXIII):
49 . The method of claim 48 , wherein R 15 is selected from the group consisting of
50 . The method of claim 49 , wherein:
R 14 is selected from the group consisting of: an alkyl group and a branched alkyl group; and R 15 is selected from the group consisting of
51 . The method of claim 50 , wherein R 16 is —NO 2 .
52 . The method of claim 51 , wherein R 14 is a branched alkyl group.
53 . The method of claim 52 , wherein:
R 14 is tent-butyl; and R 15 is selected from the group consisting of
54 . The method of claim 53 , wherein R 15 is
55 . The method of claim 48 , wherein:
R 14 is selected from the group consisting of an alkyl group and a branched alkyl group; R 15 is selected from the group consisting of
and
R 16 is —CN.
56 . The method of claim 55 , wherein:
R 14 is a branched alkyl group; R 15 is selected from the group consisting of
and
R 16 is —CN.
57 . The method of claim 56 , wherein:
R 14 is tent-butyl; and R 15 is
58 . A method of treating a viral infection or inflammatory condition, the method comprising administering a compound of formula selected from the group consisting of (LVII), (LVIII), (LIX), and (LX):
or a pharmaceutically acceptable salt thereof.
59 . The method of claim 47 , wherein the inflammatory condition is pneumonia.Join the waitlist — get patent alerts
Track US2017298020A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.